Investor Relations

The Company releases Q2 2022 earnings

Company Profile

Alps Group Inc (“Alps”) is a biotechnology and life sciences organization headquartered in Malaysia. Through its subsidiaries, Alps operates across research and development, diagnostic testing, therapeutic development, and wellness services, focused on advancing precision, preventive and personalized medicine through innovations in genomics, mRNA technologies, and cellular therapy.

Alps owns and operates a GMP cell manufacturing lab, a molecular diagnostics lab, a medical centre, and a wellness centre, forming an integrated ecosystem for biotechnology research, healthcare delivery, and patient-centered wellness solutions creating a seamless bench to bedside continuum.

With a vision to transform global health outcomes, Alps is actively expanding its footprint through strategic partnerships and international collaborations. The company’s focus on scientific excellence, regulatory compliance, and patient-centered innovation drives its mission to deliver a 'Fair Healthcare Ecosystem" through accessible, next-generation medical solutions across Southeast Asia and beyond.

ALPS Group Inc CEO Letter

ALPS team at Nasdaq Closing Bell Ceremony

Recent Reports

More information is coming soon.

Events

More events are coming soon.

Environmental, Social & Governance

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Cras porta, sapien a molestie rhoncus, odio lorem volutpat leo, at sollicitudin nisi lacus et quam. Morbi dignissim, magna vitae posuere semper, libero dolor pharetra diam, id venenatis nulla libero sed nibh.